Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Express Scripts
Accenture
Dow
Harvard Business School
QuintilesIMS
Johnson and Johnson
Teva
US Department of Justice

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019833

« Back to Dashboard

NDA 019833 describes CHILDREN'S ADVIL, which is a drug marketed by Pfizer and Wyeth Cons and is included in five NDAs. It is available from two suppliers. Additional details are available on the CHILDREN'S ADVIL profile page.

The generic ingredient in CHILDREN'S ADVIL is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.
Summary for 019833
Tradename:CHILDREN'S ADVIL
Applicant:Wyeth Cons
Ingredient:ibuprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength100MG/5ML
Approval Date:Sep 19, 1989TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Julphar
Cantor Fitzgerald
Chinese Patent Office
Colorcon
Johnson and Johnson
Mallinckrodt
Fuji
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.